Simon Borghs

839 citations

39 papers · 660 indexed · h-index 14

Impact in

Psychiatry and Mental health top 2%
- Epilepsy research and treatment
Pediatrics, Perinatology and Child Health top 2%
- Pharmacological Effects and Toxicity Studies
- Pharmaceutical studies and practices

Papers in ⓘ

Psychiatry and Mental health 39
- Epilepsy research and treatment 39
Pediatrics, Perinatology and Child Health 33
- Pharmacological Effects and Toxicity Studies 33
- Pharmaceutical studies and practices 4

Co-authors: Christine de la Loge (6 shared papers)Joyce A. Cramer (3 shared papers)Klaus Eckhardt (2 shared papers)Stephen L. Yates (2 shared papers)Wei Liang (1 shared paper)Toufic Fakhoury (1 shared paper)Joseph D’Souza (1 shared paper)Peter Dedeken (7 shared papers)
Journals: Epilepsy & Behavior (7 papers)Value in Health (7 papers)Neurology (6 papers)Epilepsia (4 papers)BMC Neurology (2 papers)
Partner nations: United Kingdom United States Belgium

In The Last Decade

Simon Borghs

37 papers receiving 644 citations

Peers

Countries citing papers authored by Simon Borghs

Since Specialization

Citations

This map shows the geographic impact of Simon Borghs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Borghs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Borghs more than expected).

Fields of papers citing papers by Simon Borghs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Borghs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Borghs. The network helps show where Simon Borghs may publish in the future.

Co-authors

The 25 scholars most cited alongside Simon Borghs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Simon Borghs Line = papers co-authored together Simon Borghs links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam Epilepsy & Behavior ·Stephen L. Yates, Toufic Fakhoury, Wei Liang, Klaus Eckhardt, Simon Borghs, Joseph D’Souza	2015	121
2	Defining minimally important change in QOLIE-31 scores: Estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures Epilepsy & Behavior ·Simon Borghs, Christine de la Loge, Joyce A. Cramer	2012	77
3	Safety, tolerability, and seizure control during long‐term treatment with adjunctive brivaracetam for partial‐onset seizures Epilepsia ·Manuel Toledo, John Whitesides, Jimmy Schiemann, Martin Johnson, Klaus Eckhardt, Belinda McDonough, Simon Borghs, Patrick Kwan	2016	60
4	Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures Neurology ·Viktor Farkas, Barbara Steinborn, J. Robert Flamini, Ying Zhang, Nancy Yuen, Simon Borghs, Ali Bozorg, Tony Daniels, Paul Martín, Hannah C. Carney, Svetlana Dimova, Ingrid E. Scheffer, (unknown)	2019	49
5	Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial Seizure ·Wendy Waldman Zadeh, Antonio Escartín, William Byrnes, Frank Tennigkeit, Simon Borghs, Ting Li, Peter Dedeken, Marc De Backer	2015	47
6	PatientsLikeMe® Online Epilepsy Community: Patient characteristics and predictors of poor health-related quality of life Epilepsy & Behavior ·Christine de la Loge, Svetlana Dimova, Knut Mueller, George Phillips, Tracy Durgin, Paul Wicks, Simon Borghs	2016	30
7	Long-term retention rates for antiepileptic drugs: A review of long-term extension studies and comparison with brivaracetam Epilepsy Research ·Manuel Toledo, Rebecca Beale, Jennifer Evans, Sara Steeves, Sami Elmoufti, R. Townsend, John Whitesides, Simon Borghs	2017	28
8	Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records BMJ Open ·Graham Powell, J. Wells Logan, Victor A. Kiri, Simon Borghs	2019	27
9	Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D Value in Health ·Brendan Mulhern, Joshua Pink, Donna Rowen, Simon Borghs, Thomas Butt, Dyfrig Hughes, Anthony G Marson, John Brazier	2016	25
10	Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial Epilepsia ·Terence J. O’Brien, Simon Borghs, Qin He, Anne‐Liv Schulz, Stephen L. Yates, Victor Biton	2020	24
11	Randomized double-blind comparison of cognitive and EEG effects of lacosamide and carbamazepine Epilepsy & Behavior ·Kimford J. Meador, David W. Loring, Alan Boyd, Javier Echauz, Suzette M. LaRoche, Naymee Velez‐Ruiz, Pearce Korb, William Byrnes, Deanne Dilley, Simon Borghs, Marc De Backer, Tyler J. Story, Peter Dedeken, Elizabeth Webster	2016	23
12	Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta‐analyses and real‐world evidence on antiepileptic drugs Epilepsia ·S Thieffry, Pavel Klein, Michel Baulac, Jonathan Plumb, Barbara Pelgrims, Sara Steeves, Simon Borghs	2020	19
13	Health care cost associated with the use of enzyme-inducing and non-enzyme–active antiepileptic drugs in the UK: a long-term retrospective matched cohort study BMC Neurology ·Simon Borghs, S Thieffry, Matthias Noack‐Rink, Peter Dedeken, Lai San Hong, Laura Byram, J. Wells Logan, Jane Chan, Victor A. Kiri	2017	16
14	Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs SHILAP Revista de lepidopterología ·A. Groth, Thomas Wilke, Simon Borghs, P Gille, Lars Joeres	2017	13
15	Determining minimally important change thresholds for the Seizure Severity Questionnaire (SSQ) Epilepsy & Behavior ·Joyce A. Cramer, Christine de la Loge, Yves Brabant, Simon Borghs	2013	12
16	Sensitivity testing of the Seizure Severity Questionnaire (SSQ) Epilepsy & Behavior ·Simon Borghs, Christine de la Loge, Yves Brabant, Joyce A. Cramer	2013	11
17	Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam Quality of Life Research ·Clara Mukuria, Tracey Young, Anju Keetharuth, Simon Borghs, John Brazier	2016	11
18	Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy Acta Neurologica Scandinavica ·Michel Baulac, William Byrnes, Paulette Williams, Simon Borghs, Elizabeth Webster, M. De Backer, Peter Dedeken	2016	10
19	Cost of epilepsy-related health care encounters in the United States Journal of Managed Care & Specialty Pharmacy ·Simon Borghs, Silky Beaty, Witesh Parekh, Linda Kalilani, Nada Boudiaf, Andrea Loewendorf	2020	9
20	Health-related quality of life in double-blind Phase III studies of brivaracetam as adjunctive therapy of focal seizures: A pooled, post-hoc analysis Epilepsy & Behavior ·Christian Brandt, Simon Borghs, Sami Elmoufti, Knut Mueller, R. Townsend, Christine de la Loge	2017	8

About Simon Borghs

Simon Borghs is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Cellular and Molecular Neuroscience, Cognitive Neuroscience and Economics and Econometrics, having authored 39 papers that have together received 660 indexed citations. Recurring topics across this work include Epilepsy research and treatment (39 papers), Pharmacological Effects and Toxicity Studies (33 papers), Neuroscience and Neuropharmacology Research (11 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical studies and practices (4 papers), Drug Transport and Resistance Mechanisms (4 papers), EEG and Brain-Computer Interfaces (3 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). The work is most often cited by research in Psychiatry and Mental health (592 citations), Pediatrics, Perinatology and Child Health (529 citations), Cellular and Molecular Neuroscience (270 citations), Medical Terminology (1 citation) and Genetics (29 citations). Simon Borghs has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Christine de la Loge, Joyce A. Cramer, Klaus Eckhardt, Stephen L. Yates, Wei Liang, Toufic Fakhoury, Joseph D’Souza, Peter Dedeken, Manuel Toledo and John Whitesides. Their work appears in journals such as Epilepsy & Behavior, Value in Health, Neurology, Epilepsia and BMC Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact